Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of Novel Oral Polio Vaccine [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and immunogenicity of a novel oral polio vaccine has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• Novel Oral Polio Vaccine

Snippet

Sponsor: Fidec Corporation | Conditions: Poliomyelitis | Phase 2 | Status: COMPLETED | Results posted: 2022-03-23